Association between testosterone levels and the metabolic syndrome in adult men

References

• Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009;30:10–22
   PubMed Web of Science ®Google Scholar
• Mesch VR, Boero LE, Siseles NO, et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric 2006;9:40–8
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Morelli A, et al. Hypogonadism and metabolic syndrome. J Endocrinol Invest 2011;34:557–67
   PubMed Web of Science ®Google Scholar
• Blouin K, Despres JP, Couillard C, et al. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism 2005;54:1034–40
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 2006;176:1524–8
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Muller DC, Metter EJ, et al. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 2007;92:3568–72
   PubMed Web of Science ®Google Scholar
• Guay A. The emerging link between hypogonadism and metabolic syndrome. J Androl 2009;30:370–6
   PubMedGoogle Scholar
• Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295:1288–99
   PubMed Web of Science ®Google Scholar
• Selvin E, Feinleib M, Zhang L, et al. Androgens and diabetes in men. Diabetes Care 2007;30:234–8
   PubMed Web of Science ®Google Scholar
• Svartberg J, von Muhlen D, Sundsfjord J, Jorde R. Waist circumference and testosterone levels in community dwelling men. The Tromso Study. Eur J Epidemiol 2004;19:657–63
   PubMed Web of Science ®Google Scholar
• Svartberg J, von Muhlen D, Schirmer H, et al. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study. Eur J Endocrinol 2004;150:65–71
   PubMed Web of Science ®Google Scholar
• Maggio M, Basaria S. Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res 2009;21:261–4
   PubMed Web of Science ®Google Scholar
• Malkin CJ, Pugh PJ, Jones RD, et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004;89:3313–18
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802–9
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486–97
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;16:1415–28
   Google Scholar
• Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003;149:601–8
   PubMed Web of Science ®Google Scholar
• Kalyani RR, Dobs AS. Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 2007;14:226–34
   PubMedGoogle Scholar
• Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested update. Aging Male 2013;16:143–50
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Arver S, Moncada I, et al. How to help the aging male? Current approaches to hypogonadism in primary care. Aging Male 2012;15:187–97
   PubMed Web of Science ®Google Scholar
• Osuna JA, Gomez-Perez R, Arata-Bellabarba G, Villaroel V. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl 2006;52:355–61
   PubMedGoogle Scholar
• Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009;5:673–81
   PubMed Web of Science ®Google Scholar
• -Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009;30:23–32
   PubMedGoogle Scholar
• Tsai EC, Matsumoto AM, Fujimoto WY, Boyho E. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 2004;27:861–8
   PubMed Web of Science ®Google Scholar
• Pitteloud N, Hardin M, Dwyer AA, et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 2005;90:2636–41
   PubMed Web of Science ®Google Scholar
• Pitteloud N, Mootha VK, Dwyer AA, et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005;28:1636–42
   PubMed Web of Science ®Google Scholar
• Muller M, Grobbee DE, den Tonkelaar I, et al. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 2005;90:2618–23
   PubMed Web of Science ®Google Scholar
• Pagotto U, Gambineri A, Pelusi C, et al. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab 2003;88:4139–43
   PubMed Web of Science ®Google Scholar
• Smith MR, Lee H, Nathan DM. Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab 2006;91:1305–8
   PubMed Web of Science ®Google Scholar
• Chubb SA, Hyde Z, Almeida OP, et al. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol 2008;158:785–92
   PubMed Web of Science ®Google Scholar
• Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 2003;24:183–217
   PubMed Web of Science ®Google Scholar
• Simon D, Charles MA, Nahoul K, et al. Association between plasma testosterone and cardiovascular risk factors in healthy adult men: the Telecom study. J Clin Endocrinol Metab 1997;82:682–5
   PubMed Web of Science ®Google Scholar
• Barud W, Palusinski R, Beltkowski J, Wojcicka G. Inverse relationship between total testosterone and anti-oxidized low-density lipoprotein antibody levels in ageing males. Atherosclerosis 2002;164:282–8
   Google Scholar
• Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 2007;92:3844–53
   PubMed Web of Science ®Google Scholar
• Saad F, Gooren LJ, Haider A, Yassin A. A dose–response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl 2008;29:102–5
   PubMed Web of Science ®Google Scholar
• Allan CA, Strauss BJG, Burger HG, et al. Testosterone therapy prevents gain in adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab 2008;93:139–46
   PubMed Web of Science ®Google Scholar
• Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older age: a randomized controlled trial. JAMA 2008;299:39–52
   PubMed Web of Science ®Google Scholar
• Berg G, Schreier L, Geloso G, et al. Impact on lipoprotein profile after long term testosterone replacement in hypogonadal men. Horm Metab Res 2002;34:87–92
   PubMedGoogle Scholar
• Smith MR, Finkelstein JS, McGovern FJ, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 2002;87:599–603
   PubMed Web of Science ®Google Scholar
• Tsompanidi EM, Brinkmeier MS, Fotiadou EH, et al. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis 2010;208:3–9
   PubMed Web of Science ®Google Scholar
• Traish A, Abdou R, Kypreos KE. Androgen deficiency and atherosclerosis: the lipid link. Vascul Pharmacol 2009;51:303–13
   PubMed Web of Science ®Google Scholar
• Bhattacharya RK, Khera M, Blick G, et al. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging 2012;7:321–30
   PubMed Web of Science ®Google Scholar